A Multicenter, Double-blind, Active-controlled, Randomized, Parallel Group Study to Demonstrate the Comparison and Evaluation of Baracle Tab and Baraclude Tab for HBeAG Chronic Hepatitis B
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Entecavir (Primary) ; EN 122001
- Indications Hepatitis B
- Focus Therapeutic Use
- 31 Aug 2017 Biomarkers information updated
- 07 Aug 2013 New trial record